Integration of safety pharmacology endpoints into toxicology studies - A survey of GLP institutions in China.
Integrating safety pharmacology (SP) endpoints into repeated-dose toxicology studies enables the simultaneous assessment of organ toxicity and determination of functional safety risks within a single study, a practice endorsed by regulatory guidelines. Initiated by the Chinese Safety Pharmacology Society, this question...